Surgery Partners’ (SGRY) Outperform Rating Reiterated at Macquarie

Macquarie reaffirmed their outperform rating on shares of Surgery Partners (NASDAQ:SGRY) in a research report report published on Monday, Benzinga reports. Macquarie currently has a $35.00 price target on the stock.

Other analysts have also issued research reports about the stock. UBS Group initiated coverage on shares of Surgery Partners in a research note on Monday, October 14th. They issued a “buy” rating and a $38.00 price objective on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a research report on Friday, October 4th. StockNews.com cut Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, August 7th. KeyCorp started coverage on Surgery Partners in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Benchmark restated a “buy” rating and set a $50.00 price target on shares of Surgery Partners in a research report on Monday, August 26th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $40.13.

Surgery Partners Stock Down 1.3 %

Shares of SGRY stock opened at $29.32 on Monday. Surgery Partners has a fifty-two week low of $22.25 and a fifty-two week high of $36.92. The firm has a market capitalization of $3.73 billion, a PE ratio of -108.59, a P/E/G ratio of 2.27 and a beta of 2.76. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.69 and a current ratio of 1.83. The stock’s 50-day simple moving average is $31.09 and its 200-day simple moving average is $28.31.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The company had revenue of $762.10 million for the quarter, compared to the consensus estimate of $735.94 million. During the same quarter in the prior year, the company earned $0.25 EPS. Surgery Partners’s quarterly revenue was up 14.2% on a year-over-year basis. Equities analysts expect that Surgery Partners will post 0.84 earnings per share for the current year.

Institutional Trading of Surgery Partners

Several large investors have recently made changes to their positions in SGRY. Principal Financial Group Inc. lifted its position in Surgery Partners by 16.3% during the first quarter. Principal Financial Group Inc. now owns 10,073 shares of the company’s stock worth $300,000 after buying an additional 1,409 shares in the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Surgery Partners by 33.7% in the 1st quarter. BNP Paribas Financial Markets now owns 421,137 shares of the company’s stock worth $12,563,000 after acquiring an additional 106,054 shares during the last quarter. Capstone Investment Advisors LLC boosted its position in shares of Surgery Partners by 38.7% during the 1st quarter. Capstone Investment Advisors LLC now owns 9,151 shares of the company’s stock worth $273,000 after purchasing an additional 2,551 shares during the period. ProShare Advisors LLC increased its holdings in Surgery Partners by 7.8% in the 1st quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock valued at $405,000 after purchasing an additional 986 shares during the last quarter. Finally, First Eagle Investment Management LLC raised its position in Surgery Partners by 16.5% in the first quarter. First Eagle Investment Management LLC now owns 339,474 shares of the company’s stock valued at $10,127,000 after purchasing an additional 48,100 shares during the period.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.